What Happened?
A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth. Trump's comments added pressure to an already sensitive market, raising concerns about political interference in monetary policy.
Meanwhile, Fed Chair Jerome Powell maintained a cautious stance the previous week, highlighting the difficulty of balancing the dual mandate of steady employment and price stability amid the escalating trade tension. Investor sentiment was further dampened by the absence of constructive progress in trade negotiations, especially US-China relations which took a turn for the worse in the previous week.
Overall, the outlook seemed more unclear heading into the first quarter 2025 earnings season, as a combination of hard to predict monetary policy and unresolved trade tensions weighed on business confidence.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, following stocks were impacted:
- Senior Health, Home Health & Hospice company AdaptHealth (NASDAQ: AHCO) fell 5.7%. Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.
- E-commerce Software company Wix (NASDAQ: WIX) fell 5.1%. Is now the time to buy Wix? Access our full analysis report here, it’s free.
- Social Networking company Pinterest (NYSE: PINS) fell 5.6%. Is now the time to buy Pinterest? Access our full analysis report here, it’s free.
- Project Management Software company Monday.com (NASDAQ: MNDY) fell 5.1%. Is now the time to buy Monday.com? Access our full analysis report here, it’s free.
- Online Marketplace company The RealReal (NASDAQ: REAL) fell 5.7%. Is now the time to buy The RealReal? Access our full analysis report here, it’s free.
Zooming In On AdaptHealth (AHCO)
AdaptHealth’s shares are very volatile and have had 29 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was about 2 months ago when the stock gained 28% on the news that the company reported strong fourth-quarter 2024 results with revenue surpassing forecasts and driving EPS well above Wall Street estimates. While full-year revenue guidance came in slightly below expectations, full-year EBITDA guidance exceeded projections. Overall, this quarter had some key positives.
AdaptHealth is down 25.4% since the beginning of the year, and at $7.24 per share, it is trading 37.6% below its 52-week high of $11.60 from June 2024. Investors who bought $1,000 worth of AdaptHealth’s shares 5 years ago would now be looking at an investment worth $485.58.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
